3 AI Stocks That Are Revolutionizing the Finance Industry

3 AI Stocks That Are Revolutionizing the Finance Industry

InvestorPlace – Inventory Market place News, Inventory Advice & Buying and selling Suggestions

AI shares have been heating up above the past few weeks.

The technological innovation is altering the construction of today’s money institutions as it weakens the connections of classic systems and creates windows of prospect for groundbreaking developments.

AI has revolutionized how we carry out firms by establishing techniques that feel and behave like humans. The use of algorithms to interpret and arrange wide amounts of details is outstanding.

These are the AI stocks to keep your eye on.

SoFi (SOFI)

Silhouette of person holding mobile phone with SoFi (SOFI) logo shown in background

Source: shutterstock.com/rafapress

SoFi (NASDAQ:SOFI) operates an revolutionary fintech business enterprise that has been a disruptive player in its area of interest.

Its item-centered method features shoppers a variety of solutions, from college student personal loan refinancing to home loans and even wealth administration solutions.

What places it among the AI shares is that it works by using AI to successfully remodel the lending method, offering buyers lessen premiums and more personal savings possible. By leveraging client data applying AI-dependent know-how, SoFi has produced a strong underwriting model.

This in depth solution gives debtors a lot more self confidence in their applications and demonstrates how the company wants to maximize buyer engagement.

The organization wrapped up its 3rd comprehensive calendar year of functions, building a stellar $30 million optimistic GAAP web money at an impressive 11{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} margin. Its membership base has developed to 5.2 million, a whopping 21{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} improvement from the conclude of 2021. SoFi expects adjusted revenue to exceed analyst anticipations.

Lemonade (LMND)

Lemonade stock logo displayed on smartphone laying on top of computer keyboard.

Resource: Stephanie L Sanchez / Shutterstock.com

Lemonade (NYSE:LMND) began off as a renters’ insurance plan product but has given that unfold its tentacles into 5 exceptional insurance policies verticals.

Its system is one of a kind due to the fact customer interactions are 100{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} electronic, which eliminates the have to have for brokers or middlemen. Additionally, it utilizes AI to carry out threat assessments, underwriting policies, and other intricate procedures.

It offers the maximum share of renter’s insurance purchasers underneath 35, beating the most significant insurance businesses. Also, it has a cross-market ratio of over 30{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} for its other insurance plan groups, which carry heftier rates than renters insurance.

Income growth for the agency has been exceptional, at in excess of 258{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over the previous five decades on ordinary. Nonetheless, the primary concern fears its reduction ratios, which have a short while ago grown by double-digit margins.

The current Metromile deal and the results of Hurricane Ian slowed down its progress towards profitability in modern quarters. Nonetheless, with pending price increases, Lemonade can successfully bring its rates nearer to risk and strengthen its base-line predicament.

Upstart (UPST)

In this photo illustration the Upstart (UPST) logo seen displayed on a smartphone screen

Supply: rafapress / Shutterstock.com

Upstart (NASDAQ:UPST) is a major fintech company specializing in delivering “AI-powered” financial loans.

Roughly $5 trillion in loans are originated each and every calendar year, and Upstart is in a potent posture to make the most out of this industry as it builds its huge marketplace.

Upstart is revolutionizing the credit marketplace. By applying innovative AI types to recognize chance properly, Upstart can approve more applicants and do so speedily and reliably. It has partnerships with 150 institutional investors and 83 banking companies, which go on to mature each individual quarter.

Irrespective of its success around the several years, its the latest performances have been deplorable, contacting into issue its extensive-term attractiveness. Upstart’s business model performs most effective in a small-possibility environment with straightforward entry to funding.

On the other hand, the high inflation and fascination level natural environment at this time has significantly impacted the firm’s prime and base-line positioning. Layer that up with its lousy funds choices, these kinds of as its share repurchasing endeavours, which has more extra to trader woes.

In excess of the extended term, its business enterprise remains appealing after the economic natural environment starts to strengthen, but it continues to be a contrarian participate in for now.

On the day of publication, Muslim Farooque did not have (possibly directly or indirectly) any positions in the securities described in this write-up. The thoughts expressed in this report are individuals of the author, matter to the InvestorPlace.com Publishing Guidelines.

Muslim Farooque is a eager trader and an optimist at heart. A lifestyle-extended gamer and tech enthusiast, he has a unique affinity for analyzing technological know-how stocks. Muslim holds a bachelor’s of science degree in applied accounting from Oxford Brookes College.

The post 3 AI Shares That Are Revolutionizing the Finance Sector appeared first on InvestorPlace.

The views and opinions expressed herein are the sights and views of the writer and do not automatically reflect individuals of Nasdaq, Inc.

3 Stocks From Flourishing SBIC & Commercial Finance Industry

3 Stocks From Flourishing SBIC & Commercial Finance Industry

The Zacks SBIC & Commercial Finance industry will continue to bear the brunt of higher prepayments as interest rates rise. This is likely to keep hurting the industry players’ profitability to some extent.

Yet, higher interest rates, favorable regulatory changes and decent economic growth are expected to keep supporting the industry in the coming days. Robust asset quality continues to act as a major tailwind. Hence, a few industry players like Ares Capital Corporation ARCC, Main Street Capital Corporation MAIN and Hercules Capital, Inc. HTGC are likely to gain from these favorable developments.

About the Industry

The Zacks SBIC & Commercial Finance industry comprises companies that provide finance to small and mid-sized privately held developing firms. These firms are typically underserved by traditional banks and other lenders. Additionally, firms suffering from financial distress are the primary target clients of these lenders. The industry players provide customized financing solutions, ranging from senior-debt instruments to equity capital. This financing is provided for a change of ownership transactions, strategic buyouts, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors, among others. Some of the other products offered by the industry participants are mezzanine loans that typically pay high-interest rates and could be converted into equity in the target firm.

3 Major Factors Shaping the Future of SBIC & Commercial Finance Industry

Rising Rates: The Federal Reserve aggressively raised interest rates last year. Though the pace of rate hikes has slowed down, the central bank is expected to keep the rates higher till the “sticky” inflation comes down reasonably. While this has led to a spike in prepayments and refinancing before interest rates climb further, higher rates will benefit SBIC & Commercial Finance industry players. Also, the demand for products and services offered by these companies is likely to keep growing. Thus, the industry players are expected to witness a solid improvement in revenues going forward.

Solid Asset Quality: Following the COVID-19 outbreak and a subsequent halt in business activities in 2020, the majority of sectors wherein SBIC & Commercial Finance companies provide loans were hit hard. This raised fears of a deterioration of asset quality for industry players. Yet, support from the administration in the form of stimulus packages, extensive vaccination drives and the re-opening of businesses continues to support economic growth. These are likely to prevent a substantial rise in delinquency rates for the industry players, though inflation remains a major near-term headwind.

Regulatory Changes: In 2018, an amendment to the Investment Company Act of 1940 by the Small Business Credit Availability Act eased leverage limits for such companies, allowing them to increase their debt-to-equity leverage to 2:1 from 1:1. This helped these companies to reduce portfolio risks by investing in higher capital structures without foregoing current returns. Thus, the act provided extra funding flexibility to these companies and will continue offering more growth opportunities.

Zacks Industry Rank Indicates Brighter Prospects

The Zacks SBIC & Commercial Finance industry is a 36-stock group within the broader Zacks Finance sector. The industry currently carries a Zacks Industry Rank #38, which places it in the top 15{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of more than 250 Zacks industries.

The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates outperformance in the near term. Our research shows that the top 50{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of the Zacks-ranked industries outperform the bottom 50{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} by a factor of more than 2 to 1.

The industry’s positioning in the top 50{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of the Zacks-ranked industries is a result of an encouraging earnings outlook for the constituent companies in aggregate. Looking at aggregate earnings estimate revisions, it appears that analysts are gradually gaining confidence in this group’s bottom-line growth potential. Over the past year, the industry’s earnings estimates for the current year have been revised 15.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} upward.

So, we are presenting a few stocks that are well-positioned to outperform the market based on a strong earnings outlook. Before that, let’s check out the industry’s recent stock market performance and valuation picture.

Industry Outperforms Sector and S&P 500

The Zacks SBIC & Commercial Finance industry has outperformed both the S&P 500 composite and its own sector over the past two years.

The stocks in this industry have collectively gained 5.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over this period, while both the Zacks S&P 500 composite and Zacks Finance sector have risen 0.3{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}.

Two-Year Price Performance

Industry’s Current Valuation

One might get a good sense of the industry’s relative valuation by looking at its price-to-tangible book ratio (P/TBV), which is commonly used for valuing loan providers because of large variations in their earnings results from one quarter to the next.

The industry currently has a trailing 12-month P/TB of 0.86X. The highest level of 1.02X, lowest of 0.40X and a median of 0.90X have been recorded by the industry over the past five years. Also, the industry is trading at a significant discount compared with the market at large, as evident from the trailing 12-month P/TB for the S&P 500 composite of 9.26X, as the chart below shows.

Price-to-Tangible Book Ratio (TTM)

 

As finance stocks typically have a low P/TB ratio, comparing SBIC & commercial loan providers with the S&P 500 may not make sense to many investors. However, a comparison of the group’s P/TB ratio with that of its broader sector ensures that the group is trading at a decent discount. The Zacks Finance sector’s trailing 12-month P/TB of 4.78X is also way above the Zacks SBIC & Commercial Finance industry’s ratio, as the chart below shows.

Price-to-Tangible Book Ratio (TTM)

3 SBIC & Commercial Finance Stocks to Bet on

Ares Capital: This Zacks Rank #1 (Strong Buy) stock is a specialty finance firm that primarily invests in U.S. middle-market companies (firms having annual earnings in the range of $10-$250 million). Based in Maryland, ARCC offers customized financing solutions, ranging from senior-debt instruments to equity capital, with a focus on senior secured debt. Its investments in corporate borrowers generally range from $30 million to $500 million, while investment in power generation projects is between $10 million and $200 million.

You can see the complete list of today’s Zacks #1 Rank stocks here.

As of Dec 31, 2022, Ares Capital had total investments (fair value) of $21.78 billion, total assets of $22.4 billion and a net asset value of $18.40 per share.

Ares Capital has been witnessing growth in total investment income over the last few years. The company is expected to continue witnessing a rise in investment income in the quarters ahead, given the regulatory changes and rising demand for customized financing. Also, its investment commitments to new and existing portfolio companies have been steadily rising.

As of Dec 31, 2022, ARCC had debt of $12.21 billion and cash and cash equivalents (including restricted cash) of $303 million. The company has a revolving credit facility, allowing it to borrow up to $3.9 billion at any time, with a maturity date of Mar 31, 2027.

To maintain its RIC status, Ares Capital distributes approximately 90{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of its taxable income. In October 2022, it announced a dividend hike of 12{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}, marking the third such increase last year.

ARCC has a market cap of $10.3 billion. Over the past six months, the company’s shares have gained 5.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The Zacks Consensus Estimate for earnings has been revised 4.4{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} upward to $2.38 for 2023 over the past 30 days.

Price and Consensus: ARCC

 

Main Street Capital: This Zacks Rank #2 (Buy) private equity firm specializes in providing equity capital to lower-middle-market (LMM) companies. Main Street Capital also offers debt capital to middle-market companies. Based in Houston, TX, MAIN invests in LMM companies that generate annual revenues between $10 million and $150 million.

As of Sep 30, 2022, Main Street Capital had total investments (fair value) of $3.74 billion in 195 portfolio companies, which consisted of investments in the LMM portfolio, the middle-market portfolio and the private loan portfolio. As of the same date, MAIN’s net asset value (NAV) was $25.94 per share.

At the end of the September quarter, Main Street Capital had total liquidity of $420.2 million, which included $61.2 million in cash and cash equivalents and $359 million of unused capacity under its revolving credit facility. As of Sep 30, 2022, MAIN had total debt worth $1.48 billion, consisting of debentures and senior notes.

Since its October 2007 initial public offering (IPO), Main Street Capital has regularly raised its monthly dividends. Cumulatively, dividends paid or declared since IPO through the third quarter of 2022 stand at $35.80 per share.

Main Street Capital has a market cap of $3.1 billion. Over the past six months, MAIN’s stock has declined 7.4{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The Zacks Consensus Estimate for earnings has been revised 1.1{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} upward to $3.62 for 2023 over the past 30 days.

Price and Consensus: MAIN

 

Hercules Capital: Headquartered in Palo Alto, CA, HTGC is a specialty finance company that provides venture capital to technology and life science-related companies. Its investments are generally between $15.0 million and $40.0 million, and it expects these to generate revenues within at least two to four years.

Despite the tough macroeconomic scenario, Hercules Capital is expected to continue witnessing the growing demand for customized financing from private equity firms and venture capitalists. The company maintains a robust balance sheet position.

As of Dec 31, 2022, it had $606.8 million in liquidity, including $15.8 million in unrestricted cash and cash equivalents and $591 million in credit facilities. Also, HTGC has long-term issuer ratings of BBB- and Baa3 from Fitch Ratings and Moody’s Investors Service, respectively, along with a stable outlook, which renders it favorable access to the debt market. At the end of the fourth quarter of 2022, the weighted average cost of debt, comprising interest and fees, was 4.6{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}.

The fair value of Hercules Capital’s total investment portfolio was $2.96 billion as of Dec 31, 2022. Net asset value was $10.53 per share on the same date.

HTGC’s concentrated focus on its credit performance is encouraging. Driven by the rise in the demand for customized financing and a robust deal pipeline, total new commitments are expected to keep increasing.

Hercules Capital’s capital deployment plan seems impressive. It announced a 2.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} hike in the quarterly distribution in October 2022, following hikes of 6.1{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} in July, 3.1{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} in October 2021 and 3.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} in May 2019. Management revisits its dividend policy at the end of every quarter and determines if any changes are required.

Hercules Capital has a market cap of $2.1 million. Shares of this Zacks Rank #2 company have rallied 5.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over the past six months. The Zacks Consensus Estimate for 2023 earnings has been revised 2.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} north to $1.80 over the past month.

Price and Consensus: HTGC

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Ares Capital Corporation (ARCC) : Free Stock Analysis Report

Hercules Capital, Inc. (HTGC) : Free Stock Analysis Report

Main Street Capital Corporation (MAIN) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Top 5 Auto Stocks For 2023

Top 5 Auto Stocks For 2023

Crucial Takeaways

  • With the chip lack in excess of, additional cars and trucks are producing it to seller loads, raising the stock, and solutions for customers by extension.
  • Lots of automakers carry on to force into the electric car or truck place by supplying new EV models.
  • See checklist down below for the most important automobile makers to look at.

2023 really should be an exciting 12 months for automakers as they uncover approaches to maintain profitability, manage their inventories as offer chain woes vanish, and glimpse towards the long run with electric autos.

Here’s what individuals and investors can assume from the international auto marketplace in 2023, along with a couple of particular car makers that could be truly worth investing in.

2023 Outlook

Automakers are on the lookout for new revenue streams and concentrating on the consumer’s wallet as the supply. Charges for new automobiles are increasing in 2023 even as supply chain troubles are allowing up.

Several automakers are producing subscription options for characteristics like heated seats and steering wheels, driver assist systems, and employing a smartphone app to join to a auto. Customers can expect additional membership designs and larger expenses for attractive functions.

Offer chain difficulties plaguing the automotive sector for the very last two years are improving. Backorders are becoming filled, and frequent production is expected to resume in 2023.

The automotive business is at danger of oversupplying autos to the industry. These cars may well or might not be conveniently absorbed. Automakers danger depressing the selling price of their product or service if this occurs if numerous autos sit on dealership plenty.

TryqAbout the Emerging Tech Package | Q.ai – a Forbes enterprise

Gas cell electric powered cars (FCEVs) are starting to be an option to electric powered cars and trucks, with Toyota placing the finest investment into this technologies. The FCEV works by using hydrogen to electricity a car or truck in the identical way as the batteries of an electric powered automobile, but it employs pure hydrogen for propulsion.

This technological innovation just isn’t completely ready for professional creation, but developments in gasoline cell technological know-how are bringing the FCEV closer to business fact and even further complicating matters for the auto marketplace, currently scrambling to deliver greater EVs to industry.

Thrust for Electric powered Cars

The drive to move into electric powered cars primarily comes from decreasing carbon emissions and reliance on oil generation.

Outside the house of the electricity fees of producing and charging, EVs bring about the the very least air pollution. A lot more automobiles on the road that are all-electric powered, hybrid, or electric powered support (EA) lowers strength prices and air pollution apart from an adverse celebration.

Electric motor vehicles are also extra straightforward to generate mainly because they really don’t require the design of an motor alongside with the chassis. Automakers can carry on to count on their chassis-creating know-how although offering the upcoming generation of vehicular propulsion.

In the meantime, purchasers can even now invest in their favourite make and model but now have the possibility to invest in it with an electric or conventional motor.

Even however companies are pushing hard into the EV space, they are not supplying up on creating internal combustion engines just nonetheless, specifically for pickups. EVs can tow, but towing rapidly drains the charge on an EV, producing it a bad alternative for towing.

As a outcome, you can anticipate EVs and interior combustion motor vehicles to coexist on vendor loads for 2023 and past.

The most well known difficulty EVs experience arrives from a deficiency of charging infrastructure. Urban places that would profit the most from EV adoption have even a lot more limited charging infrastructure. This dissuades many would-be consumers from owning an all-electrical car or truck.

Automakers to Observe in 2023

All automobile manufacturers possibly release new motor vehicles yearly or refresh their latest lineup. In 2023 nevertheless, sure automakers are currently being intently viewed by traders for a variety of factors.

Right here are some of the most talked about car shares and what 2023 holds for them.

Tesla

Tesla is looking to stay in advance of the opposition in 2023 with the introduction of the Cybertruck by the finish of the 12 months, an maximize in the generation of its Design Y, and the introduction of a new base product that starts at $25,000.

The company also just lately released the Tesla Semi. It stands to advantage from different federal authorities tax incentives that assistance lessen the price of its automobiles and boost income.

Nevertheless, the organization is starting off the 12 months on the wrong foot. On January 3, 2023, Tesla announced that it skipped its 2022 deliveries target. This sent the stock down around 10{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} for the day, on prime of the far more than 70{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} decrease very last year.

Ford

Ford is pushing forward with its prepare to construct 600,000 EVs by the conclusion of 2023 and improve creation to two million by 2026.

It at this time gives the following nameplates in EV versions for 2023:

  • Maverick
  • Escape (hybrid and plug-in hybrid)
  • F-150 Lightning
  • Mustang Mach-E
  • E-Transit
  • Explorer Confined

The huge news is that much more Ford F-150 Lightnings will be shipped to clients waiting who have been patiently to receive their trucks. Traders are also awaiting economic effects to see how the firm’s price tag-chopping moves have impacted the bottom line.

Standard Motors

CEO Mary Barra introduced plans for a conservative 2023 in terms of manufacturing and profits. The very expected Hummer EV will be bought by the GMC division and badged as the GMC Hummer in 2023.

Ms. Barra also pointed out that the company aims to make and market only electrical passenger motor vehicles by 2035. In addition, it is shifting creation at five assembly plants to create EV-only types.

GM’s EV lineup for 2023 consists of the adhering to:

  • Chevrolet Equinox
  • Chevrolet Blazer
  • Chevrolet Silverado RST (2024 product arriving in 2023)
  • Bolt EV and EUV

Volvo

Volvo is pushing toward its target of making all of its products as EVs by 2030, and established 2025 as the halfway position for accomplishing that goal. It at this time delivers two EVs, the C40 crossover and XC40 Recharge, and two hybrids, the XC90 Recharge and the XC60 Recharge.

The carmaker options to produce sustainable vehicles and works by using as a lot of recyclable supplies to manufacture its automobiles as achievable, which includes exteriors, powertrains, and even interiors.

BMW

BMW is on the lookout for a slight increase in income development for 2023 and desires to accomplish 10{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} sales for fully electrical cars. Provided is the redesigned 7 Series, readily available in gas or electric powered powertrains.

The business is also searching to put apart the backlash it faced in 2022 above the plan of charging customers for heated seats in their cars.

Bottom Line

Automakers are wanting ahead to a robust 2023 as new electric vehicles become a lot more prevalent on the roads. This could guide to strong earnings and terrific financial investment opportunities for those paying for vehicle shares.

Even so, if the financial system goes south quickly or falls into an formal economic downturn, the vehicle field – among other individuals – will take its share of the pain.

If you aren’t absolutely sure incorporating vehicle stocks to your portfolio is the right option for your investing ambitions or risk tolerance, Q.ai can assist. Our artificial intelligence scours the markets for the ideal investments for all method of hazard tolerances and financial circumstances. Then, it bundles them up in helpful Financial commitment Kits that make investing straightforward and strategic.

Best of all, you can activate Portfolio Protection at any time to protect your gains and reduce your losses, no matter what sector you spend in.

Down load Q.ai these days for access to AI-powered investment decision procedures.

4 Stocks to Watch Amid a Challenging Outpatient Home Health Industry

3 AI Stocks That Are Revolutionizing the Finance Industry

The pandemic altered the nature and dynamics of the healthcare industry. The Zacks Medical – Outpatient and Home Healthcare industry bore the brunt of lower outpatient clinic visits and struggled to provide quality care with respect to home healthcare due to the risk of exposure to the virus as well as the record level of staffing shortages. The decline in the severity of the pandemic was followed by the mass opening up of the economy. However, risks related to the emergence of several subvariants of Omicron, including XBB and BQ.1.1, loom large on the U.S. MedTech sector. On a positive note, rising dependence on telehealth and artificial intelligence (AI) is likely to help the industry thrive in the near term. Option Care Health, Inc. OPCH, LifeStance Health Group, Inc. LFST, Addus HomeCare Corporation ADUS and The Pennant Group, Inc. PNTG are likely to gain from the prospects.

Industry Description

The industry comprises companies that offer ambulatory care in an outpatient setting or at home. These companies use advanced medical technologies for diagnosis, observation, consultation, treatment and rehabilitation services. The industry participants also include operators of HMO medical centers, kidney dialysis centers, freestanding ambulatory surgical units, emergency centers and other outpatient care centers. Some of the companies in this space have been at the forefront of the COVID-19 pandemic response since 2020 by expanding access to laboratory insights to enable people to lead healthier and safer lives through both molecular diagnostic and antibody serology tests, which help in the diagnosis of COVID-19 and the identification of immune response to the virus.

Major Trends Shaping the Future of the Outpatient and Home Healthcare Industry

Cost Effectiveness: The primary advantage of outpatient clinics is cost-effectiveness. Outpatient medical care clinics do not retain patients for long hours (overnight) or charge exorbitantly. Notably, modern-day outpatient clinics offer a broad spectrum of treatment and diagnostic options and even minor surgical procedures. Financial incentives like health plans and government program payment policies supporting services in lower-cost care settings have also been driving outpatient care. In fact, this is the primary reason why middle-class Americans, making up more than 62{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of the total population, prefer outpatient clinic visits.

Participating in Alternative Payment Models: It only seems reasonable for outpatient clinics to shift from fee-for-service (FFS) to alternative payment models (APM) with shared savings, risk, bundled payments or population-based payments. With value-based models of care steadily emerging as the future of healthcare, this shift is an ongoing parallel trend. FFS will be crucial to care organizations as a benchmark by which providers can assess alternative payment models. By obtaining the payment schedule from payers and comparing it to the organization’s FFS reimbursements from the same payer, providers can ascertain APM that would be financially the most advantageous to its operation.

AI’s Dominant Role: AI has been a roaring success in healthcare. It’s no wonder that it has taken the outpatient and home healthcare space by storm. Outpatient companies prefer bots and automated techniques for managing health information. With the help of AI, hospitals have been achieving better outcomes, with patients receiving more efficient and personalized care. The outpatient industry has been generating huge profits from Electronic Health Records, Revenue Cycle Management, eLabs and ePrescriptions.

Increased Dependence on Telehealth: The pandemic resulted in a decline in outpatient clinic visits. Home healthcare providers struggled to offer quality care due to the risk of exposure to the virus. Though the impact of the pandemic has been far-reaching, it has accelerated healthcare innovation. Visits to outpatient clinics have been witnessing a noticeable rebound, with the majority of people being vaccinated. But there are patients who want to be cautious and are resorting to telehealth. Meanwhile, home healthcare can gain from the benefits provided by Medicare (and several other payers) that comprise a broad range of services that can be delivered in a patient’s home, including post-operative and chronic wound care, rehabilitation, and physical therapy. These services serve as lifelines for vulnerable patients, including the Medicare population, who can suffer from complications arising from COVID-19. Moreover, home healthcare has seen a surge in the utilization of the telehealth platform in response to the pandemic.

A notable trend that has been emerging in this respect is the increasing popularity of the hybrid mode of treatment. As there are certain chronic health conditions, which cannot be identified over a telephone or video call, patients are embracing the hybrid mode of seeking treatments from their physicians in those cases.

Prominent Role of Remote Patient Monitoring: Remote patient monitoring (RPM) has been gradually gaining ground since the pandemic. During that phase, it was difficult to keep a watch on non-COVID patients in the hospital care setting as hospital capacities were brimming with COVID-19 patients. Thus, non-critical patients were increasingly being provided with healthcare in the comfort of their homes while being remotely monitored by their care providers. Even with the gradual return to normalcy, patients are increasingly preferring to be monitored from their homes via RPM devices. This is also boosting home healthcare services as vulnerable patients can be safely and adequately cared from the home setting instead of hospital settings, where the risk of COVID-19 or other infections persists.

Zacks Industry Rank

The Zacks Medical – Outpatient and Home Healthcare industry falls within the broader Zacks Medical sector. It carries a Zacks Industry Rank #210, which places it in the bottom 15{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of nearly 250 Zacks industries.

The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates bleak near-term prospects. Our research shows that the top 50{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of the Zacks-ranked industries outperforms the bottom 50{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} by a factor of more than 2 to 1.

Before we present a few outpatient home health stocks that you may want to consider for your portfolio, let’s take a look at the industry’s recent stock-market performance and valuation picture.

Industry’s Stock Market Performance

The industry has underperformed both its sector and the Zacks S&P 500 composite in the past year.

The industry has declined 32.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over this period compared with the S&P 500’s decline of 22.3{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The broader sector has declined 20.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} in the same time frame.

One Year Price Performance

Zacks Investment Research
Image Source: Zacks Investment Research

Industry’s Current Valuation

On the basis of the forward 12-month price-to-earnings (P/E), which is commonly used for valuing medical stocks, the industry is currently trading at 26.6X compared with the S&P 500’s 17.1X and the sector’s 22.5X.

Over the last five years, the industry has traded as high as 31.5X and as low as 16.8X, with the median being at 21X, as the charts below show.

Price-to-Earnings Forward Twelve Months (F12M)

Zacks Investment Research
Image Source: Zacks Investment Research

Price-to-Earnings Forward Twelve Months (F12M)

Zacks Investment Research
Image Source: Zacks Investment Research

4 Bankable Outpatient and Home Healthcare Stocks

LifeStance Health Group: LifeStance Health Group is a renowned provider of outpatient mental health care. The company announced its third-quarter 2022 results last month, wherein it registered a solid uptick in its overall revenues. It also recorded a robust improvement in its total clinicians in the reported quarter. Management is currently focusing on continuing its shift to organic growth, investing in strategic initiatives to build scalable infrastructure and driving operating leverage and profitability. LFST carries a Zacks Rank of 3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Price and Consensus: LFST

Zacks Investment Research
Image Source: Zacks Investment Research

For this Scottsdale, AZ-based company, the Zacks Consensus Estimate for 2022 revenues suggests growth of 26.8{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The same for earnings indicates an increase of 39.1{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The company’s P/B ratio of 1.1 compares favorably with the industry’s 2.1.

Addus HomeCare: Addus HomeCare’s services and operating model address a number of crucial needs across the healthcare continuum. In October, the company announced its third-quarter 2022 results, where it registered a solid uptick in its net service revenues. Management confirmed that its personal care revenues (accounting for 74.5{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of overall revenue) improved on a same-store basis. For its home health business, Addus HomeCare achieved a robust organic growth rate in new admissions and total volumes on a same-store basis. ADUS carries a Zacks Rank of 3.

Price and Consensus: ADUS

Zacks Investment Research
Image Source: Zacks Investment Research

For this company, the Zacks Consensus Estimate for 2022 revenues suggests growth of 9.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The company’s return on equity (ROE) of 8.5{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} compares favorably with the industry’s 5.8{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}.

Option Care Health: Option Care Health is a renowned independent provider of home and alternate site infusion services. In October, the company announced its third-quarter 2022 results, where it registered a solid uptick in its net revenues. At the time of the earnings release, Option Care Health confirmed that it has completed the acquisition of Rochester Home Infusion, Inc. OPCH carries a Zacks Rank of 3.

Price and Consensus: OPCH

Zacks Investment Research
Image Source: Zacks Investment Research

For this Bannockburn, IL-based company, the Zacks Consensus Estimate for 2022 revenues suggests growth of 14.6{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The same for earnings indicates an increase of 31.7{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The company’s ROE of 11.8{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} compares favorably with the industry’s 5.8{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}.

The Pennant Group: The Pennant Group is the parent company of the Pennant group of affiliated home health, hospice and senior living companies. It reported its third-quarter 2022 results last month, where it witnessed solid improvement in its overall top line. Its Home Health and Hospice Services segment recorded a robust uptick in revenues, whereas the company also recorded strength in its total home health admissions and total Medicare home health admissions. The uptick in total hospice admissions and same-store senior living revenues for the third quarter was also impressive. PNTG carries a Zacks Rank of 3.

Price and Consensus: PNTG

Zacks Investment Research
Image Source: Zacks Investment Research

For this Eagle, ID-based company, the Zacks Consensus Estimate for 2022 revenues suggests growth of 5.5{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The same for earnings indicates an increase of 23.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The company’s ROE of 9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} compares favorably with the industry’s 5.8{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}.

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} in little more than 9 months and NVIDIA which boomed +175.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} in one year.

Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Option Care Health, Inc. (OPCH) : Free Stock Analysis Report

Addus HomeCare Corporation (ADUS) : Free Stock Analysis Report

The Pennant Group, Inc. (PNTG) : Free Stock Analysis Report

LifeStance Health Group, Inc. (LFST) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

3 Stocks From the Promising SBIC & Commercial Finance Industry

3 AI Stocks That Are Revolutionizing the Finance Industry

The Zacks SBIC & Commercial Finance industry will continue to bear the brunt of higher prepayments as interest rates rise. This will likely keep hurting the industry players’ profitability to some extent.

Yet, higher interest rates, favorable regulatory changes and decent economic growth are expected to keep supporting the industry in the coming days. Robust asset quality continues to act as a major tailwind. Hence, a few industry players like Ares Capital Corporation ARCC, Main Street Capital Corporation MAIN and Hercules Capital, Inc. HTGC are likely to gain from these favorable developments.

About the Industry

The Zacks SBIC & Commercial Finance industry comprises companies that provide finance to small and mid-sized privately-held developing firms. These firms are typically underserved by traditional banks and other lenders. Additionally, firms suffering from financial distress are the primary target clients of these lenders. The industry players provide customized financing solutions ranging from senior-debt instruments to equity capital. This financing is provided for change of ownership transactions, strategic buyouts, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors, among others. Some of the other products offered by the industry participants are mezzanine loans that typically pay high-interest rates and could be converted into equity in the target firm.

3 Major Factors Shaping the Future of SBIC & Commercial Finance Industry

Rising Rates: The Federal Reserve has been aggressively raising interest rates this year, and such moves are expected to continue in the coming days to control raging inflation numbers. While this has led to a spike in prepayments and refinancing before interest rates climb further, higher rates will benefit SBIC & Commercial Finance industry players. Also, given the decent economic growth, demand for products and services offered by these companies is likely to keep growing. Thus, the industry players are expected to witness a solid improvement in revenues going forward.

Solid Asset Quality: Following the coronavirus outbreak and subsequent halt in business activities in 2020, the majority of sectors wherein SBIC & Commercial Finance companies provide loans were hit hard. This raised fears of a deterioration of asset quality for industry players. Yet, support from the administration in the form of stimulus packages, extensive vaccination drives and re-opening of businesses continue to support economic growth. These are likely to prevent a substantial rise in delinquency rates for the industry players, though inflation remains a headwind.

Regulatory Changes: In 2018, an amendment to the Investment Company Act of 1940 by the Small Business Credit Availability Act eased the leverage limits for such companies, allowing them to increase their debt-to-equity leverage to 2:1 from 1:1. This helped these companies to reduce portfolio risk by investing in higher capital structures without foregoing current returns. In other words, the act provided extra funding flexibility to these companies and will continue offering more growth opportunities.

Zacks Industry Rank Indicates Brighter Prospects

The Zacks SBIC & Commercial Finance industry is a 36-stock group within the broader Zacks Finance sector. The industry currently carries a Zacks Industry Rank #14, which places it in the top 6{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of more than 250 Zacks industries.

The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates outperformance in the near term. Our research shows that the top 50{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of the Zacks-ranked industries outperform the bottom 50{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} by a factor of more than 2 to 1.

The industry’s positioning in the top 50{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of the Zacks-ranked industries is a result of encouraging earnings outlook for the constituent companies in aggregate. Looking at the aggregate earnings estimate revisions, it appears that analysts are gradually gaining confidence in this group’s bottom-line growth potential. Over the past year, the industry’s earnings estimates for the current year have been revised 13.3{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} upward.

Hence, we are presenting a few stocks that are well-positioned to outperform the market based on a strong earnings outlook. Before that, let’s check out the industry’s recent stock market performance and valuation picture.

Industry Outperforms Sector and S&P 500

The Zacks SBIC & Commercial Finance industry has outperformed both the S&P 500 composite and its own sector over the past year.

While the stocks in this industry have collectively lost 11.5{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over this period, the Zacks S&P 500 composite and Zacks Finance sector have declined 21.5{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} and 17.5{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}, respectively.

One-Year Price Performance

 

Industry’s Current Valuation

One might get a good sense of the industry’s relative valuation by looking at its price-to-tangible book ratio (P/TBV), which is commonly used for valuing loan providers because of large variations in their earnings results from one quarter to the next.

The industry currently has a trailing 12-month P/TB of 0.82X. The highest level of 1.03X, lowest of 0.40X, and a median of 0.92X have been recorded by the industry over the past five years. Also, the industry is trading at a significant discount compared with the market at large, as is evident from the trailing 12-month P/TB for the S&P 500 composite of 9.79X, as the chart below shows.

Price-to-Tangible Book Ratio (TTM)

 

As finance stocks typically have a low P/TB ratio, comparing SBIC & commercial loan providers with the S&P 500 may not make sense to many investors. But a comparison of the group’s P/TB ratio with that of its broader sector ensures that the group is trading at a decent discount. The Zacks Finance sector’s trailing 12-month P/TB of 4.37X is also way above the Zacks SBIC & Commercial Finance industry’s ratio, as the chart below shows.

Price-to-Tangible Book Ratio (TTM)

 

3 SBIC & Commercial Finance Stocks to Invest

Ares Capital: This Zacks Rank #2 (Buy) stock is a specialty finance firm that primarily invests in U.S. middle-market companies (firms having annual earnings in the range of $10-$250 million). Based in Maryland, ARCC offers customized financing solutions, ranging from senior-debt instruments to equity capital, with a focus on senior secured debt. Its investments in corporate borrowers generally range from $30 million to $500 million while investment in power generation projects is between $10 million and $200 million.

As of Sep 30, 2022, Ares Capital had total investments (fair value) of $21.34 billion, total assets of $22.04 billion and a net asset value (NAV) of $18.56 per share.

Ares Capital has been witnessing growth in total investment income over the last few years. The company is expected to continue witnessing a rise in investment income in the quarters ahead, given the regulatory changes and rising demand for customized financing. Also, its investment commitments to new and existing portfolio companies have been steadily rising.

As of Sep 30, 2022, ARCC had a debt of $11.82 billion and cash and cash equivalents (including restricted cash) of $257 million. The company has a revolving credit facility, allowing it to borrow up to $4.3 billion at any time, with a maturity date of Mar 31, 2027.

In order to maintain its RIC status, Ares Capital distributes approximately 90{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of its taxable income. In October 2022, it announced a dividend hike of 12{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}, marking the third such increase this year. Also, it has a share repurchase program worth $500 million in place, which will expire on Feb 15, 2023.

ARCC has a market cap of $9.7 billion. Over the past 12 months, the company’s shares have lost 7.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The Zacks Consensus Estimate for earnings has been revised 5.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} upward to $2.04 for 2022 over the past 30 days.

Price and Consensus: ARCC

 

Main Street Capital: This Zacks Rank #1 (Strong Buy) private equity firm specializes in providing equity capital to lower middle-market (LMM) companies. Main Street Capital also offers debt capital to middle-market companies. Based in Houston, TX, MAIN invests in LMM companies that generate annual revenues between $10 million and $150 million.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

As of Sep 30, 2022, Main Street Capital had total investments (fair value) of $3.74 billion in 195 portfolio companies, which consisted of investments in the LMM portfolio, middle-market portfolio and private loan portfolio. As of the same date, MAIN’s NAV was $25.94 per share.

At the end of the September quarter, Main Street Capital had total liquidity of $420.2 million, which included $61.2 million in cash and cash equivalents and $359 million of unused capacity under its revolving credit facility. As of Sep 30, 2022, MAIN had total debt worth $1.48 billion, consisting of debentures and senior notes.

Since its October 2007 initial public offering (IPO), Main Street Capital has regularly raised its monthly dividends. Cumulatively dividends paid or declared since IPO through the third quarter of 2022 stand at $35.80 per share.

Main Street Capital has a market cap of $2.9 billion. Over the past 12 months, MAIN’s stock has declined 16.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The Zacks Consensus Estimate for earnings has been revised 4.7{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} upward to $3.15 for 2022 over the past 30 days.

Price and Consensus: MAIN

 

Hercules Capital: Headquartered in Palo Alto, CA, HTGC is a specialty finance company that provides venture capital to technology and life science-related companies. Its investments are generally between $15.0 million and $40.0 million, and it expects these to generate revenues within at least two to four years.

Despite the tough macroeconomic scenario, Hercules Capital is expected to continue witnessing growing demand for customized financing from private equity firms and venture capitalists. The company maintains a robust balance sheet position.

As of Jun 30, 2022, it had $700.1 million in liquidity, including $57.1 million in unrestricted cash and cash equivalents and $643.4 million in credit facilities. Also, HTGC has long-term issuer ratings of BBB- and Baa3 from Fitch Ratings and Moody’s Investors Service, respectively, along with a stable outlook, which renders it favorable access to the debt market. At the end of the third quarter of 2022, the weighted average cost of debt, comprising interest and fees, was 4.4{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}.

The fair value of Hercules Capital’s total investment portfolio was $2.83 billion as of Sep 30, 2022. NAV was $10.47 per share on the same date.

HTGC’s concentrated focus on its credit performance is encouraging. Driven by the rise in demand for customized financing and a robust deal pipeline, total new commitments are expected to keep increasing.

Hercules Capital’s capital deployment plan seems impressive. It announced a 2.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} hike in the quarterly distribution in October 2022, following hikes of 6.1{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} in July, 3.1{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} in October 2021 and  3.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} in May 2019. Management revisits its dividend policy at the end of every quarter and determines if any changes are required.

Hercules Capital has a market cap of $1.8 million. Shares of this Zacks Rank #1 company have declined 18.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over the past year. The Zacks Consensus Estimate for 2022 earnings has been revised 5.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} north to $1.43 over the past month.

Price and Consensus: HTGC

 

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} in little more than 9 months and NVIDIA which boomed +175.9{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} in one year.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Ares Capital Corporation (ARCC): Free Stock Analysis Report
 
Hercules Capital, Inc. (HTGC): Free Stock Analysis Report
 
Main Street Capital Corporation (MAIN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.